Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling

Yun Dai, Hongmei Jiao, Guigen Teng, Weihong Wang, Rongxin Zhang, Yunhong Wang, Lionel Hebbard, Jacob George, Liang Qiao

Mol Cancer Ther (2014) 13 (5): 1206–1216.

https://doi.org/10.1158/1535-7163.MCT-13-0378

Published: 05 May 2014

View articletitled, Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling

Journal Articles

The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

Yun Dai, Shuang Chen, Maciej Kmieciak, Liang Zhou, Hui Lin, Xin-Yan Pei, Steven Grant

Mol Cancer Ther (2013) 12 (6): 878–889.

https://doi.org/10.1158/1535-7163.MCT-12-0902

Published: 09 June 2013

View articletitled, The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

Includes: Supplementary data

Journal Articles

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer

Yun Dai, Liang Qiao, Kwok Wah Chan, Mo Yang, Jieyu Ye, Rongxin Zhang, Juan Ma, Bing Zou, Colin S.C. Lam, Jide Wang, Roberta Pang, Victoria P.Y. Tan, H.Y. Lan, Benjamin C.Y. Wong

Mol Cancer Ther (2009) 8 (9): 2762–2770.

https://doi.org/10.1158/1535-7163.MCT-09-0509

Published: 17 September 2009

View articletitled, Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer

Journal Articles

Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor γ ligand-induced growth inhibition in colon cancer

Liang Qiao, Yun Dai, Qing Gu, Kwok Wah Chan, Bing Zou, Juan Ma, Jide Wang, Hui Y. Lan, Benjamin C.Y. Wong

Mol Cancer Ther (2008) 7 (7): 2203–2211.

https://doi.org/10.1158/1535-7163.MCT-08-0326

Published: 21 July 2008

View articletitled, Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor γ ligand-induced growth inhibition in colon cancer

Journal Articles

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

Hossein Hamed, William Hawkins, Clint Mitchell, Donna Gilfor, Guo Zhang, Xin-Yan Pei, Yun Dai, Michael P. Hagan, John D. Roberts, Adly Yacoub, Steven Grant, Paul Dent

Mol Cancer Ther (2008) 7 (3): 616–629.

https://doi.org/10.1158/1535-7163.MCT-07-2376

Published: 17 March 2008

View articletitled, Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

Journal Articles

Ras-dependent activation of ERK1/2 regulates the lethality of Chk1 inhibitors in multiple myeloma cells

Yun Dai, Shuang Chen, Xin-Yan Pei, Jorge Almenara, Lora Kramer, Charis Venditti, Paul Dent, Steven Grant

Mol Cancer Ther (2007) 6 (11_Supplement): C180.

Published: 01 November 2007

View articletitled, Ras-dependent activation of ERK1/2 regulates the lethality of Chk1 inhibitors in multiple myeloma cells

Journal Articles

The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH₂-terminal kinase–dependent mechanism

Xin-Yan Pei, Yun Dai, Steven Grant

Mol Cancer Ther (2004) 3 (12): 1513–1524.

https://doi.org/10.1158/1535-7163.1513.3.12

Published: 04 January 2005

View articletitled, The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism

Journal Articles

Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells

Roberto R. Rosato, Jorge A. Almenara, Yun Dai, Steven Grant

Mol Cancer Ther (2003) 2 (12): 1273–1284.

Published: 05 January 2004

View articletitled, Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling

The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer

Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor γ ligand-induced growth inhibition in colon cancer

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

Ras-dependent activation of ERK1/2 regulates the lethality of Chk1 inhibitors in multiple myeloma cells

The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH₂-terminal kinase–dependent mechanism

Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only